MEDICINA
DEPARTAMENTO
Hospital Juan Ramón Jiménez
Huelva, EspañaPublicacións en colaboración con investigadores/as de Hospital Juan Ramón Jiménez (73)
2024
-
Non-Classical Effects of FGF23: Molecular and Clinical Features
International Journal of Molecular Sciences, Vol. 25, Núm. 9
2023
-
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci
International Journal of Antimicrobial Agents, Vol. 62, Núm. 3
-
Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)
Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383
-
Standards for the Use of Enteral Nutrition in Patients with Diabetes or Stress Hyperglycaemia: Expert Consensus
Nutrients, Vol. 15, Núm. 23
2022
-
Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat
Journal of Clinical Medicine, Vol. 11, Núm. 1
-
Characterization of hereditary transthyretin cardiac amyloidosis in Spain
Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 488-495
-
High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use
Journal of Infection, Vol. 85, Núm. 3, pp. 322-326
-
Story of two sisters with kidney disease: Genetics command
Nefrologia
-
Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial)
PLoS ONE, Vol. 17, Núm. 12 December
-
Weight changes after first-line antiretroviral initiation in a cohort of HIV-positive patients in Southern Spain (CAPOTA study)
International Journal of STD and AIDS, Vol. 33, Núm. 13, pp. 1119-1123
2021
-
Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study
Infectious Diseases, Vol. 53, Núm. 10, pp. 755-763
-
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Journal of Hepatology, Vol. 74, Núm. 4, pp. 801-810
-
Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response
AIDS (London, England), Vol. 35, Núm. 13, pp. 2119-2127
-
Progression to hepatitis C virus micro-elimination in people living with HIV in Spain
Clinical Microbiology and Infection
-
Real-world data of fulvestrant as first-line treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer
Scientific Reports, Vol. 11, Núm. 1
2020
-
Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis
BMC Infectious Diseases, Vol. 20, Núm. 1
-
Phosphate disorders and clinical management of hypophosphatemia and hyperphosphatemia
Endocrinologia, Diabetes y Nutricion, Vol. 67, Núm. 3, pp. 205-215
-
Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)
Scientific Reports, Vol. 10, Núm. 1
2019
-
Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH
Gastroenterologia y Hepatologia, Vol. 42, Núm. 10, pp. 657-676
-
DALBACEN cohort: Dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
Annals of Clinical Microbiology and Antimicrobials, Vol. 18, Núm. 1